Among active 13F managers last quarter, 4 opened and 2 added, while 1 reduced; the largest holder to move was Ikarian Capital, LLC (new position). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
15 tracked 13F filers disclose a position in ENVB as of the latest SEC 13F filings, a combined $321K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Ikarian Capital, LLC | 100K | $138K | ▲New +100K sh | Q2 2026 | |
| 2 | AdvisorShares Investments LLC | 35K | $49K | ▲+109% Added · +18K sh | Q2 2026 | |
| 3 | Boothbay Fund Management, LLC | 30K | $42K | ▲New +30K sh | Q2 2026 | |
| 4 | Vanguard Capital Management LLC | 15K | $21K | ▲New +15K sh | Q2 2026 | |
| 5 | Citadel Advisors LLC | 14K | $19K | ▲New +14K sh | Q2 2026 | |
| 6 | StoneX Group Inc. | 12K | $22K | ▲New +12K sh | Q2 2026 | |
| 7 | Geode Capital Management, LLC | 12K | $16K | ▼−63% Reduced · −20K sh | Q2 2026 | |
| 8 | UBS Group AG | 4K | $7K | ▲+25% Added · +717 sh | Q1 2026 | |
| 9 | SBI Securities Co., Ltd. | 3K | $4K | ▲32× Added · +3K sh | Q2 2026 | |
| 10 | Tower Research Capital LLC (TRC) | 1K | $2K | ▼−42% Reduced · −814 sh | Q1 2026 | |
| 11 | Jones Financial Companies LLLP | 1K | $2K | ▲New +1K sh | Q1 2026 | |
| 12 | BlackRock, Inc. | 51 | $70 | —Held | Q2 2026 | |
| 13 | Wells Fargo & Company | 1 | $2 | —Held | Q1 2026 | |
| 14 | National Bank Of Canada | 1 | $2 | —Held | Q1 2026 | |
| 15 | Danske Bank A/s | 1 | $1 | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 4 funds opened a new position in ENVB and 2 added to an existing one, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Neuronetics IncSTIM | 7 funds | $2.7M |
| Vistagen Therapeutics IncVTGN | 7 funds | $270K |
| Nvidia CorpNVDA | 6 funds | $3.0B |
| Apple IncAAPL | 6 funds | $2.4B |
| Microsoft CorpMSFT | 6 funds | $1.6B |
| Alphabet Inc-CL CGOOG | 6 funds | $1.0B |
| Applied Materials IncAMAT | 6 funds | $832.4M |
| Abbvie IncABBV | 6 funds | $830.2M |
| Abbott LaboratoriesABT | 6 funds | $792.9M |
| Kla CorpKLAC | 6 funds | $785.0M |
| Netflix IncNFLX | 6 funds | $680.0M |
| Lam Research CorpLRCX | 6 funds | $657.9M |
Ranked by how many of ENVB's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ENVB.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 15, 2023 | Pasqualone Frank | Director | Buy (P) | 1K | $2K |
| Nov 16, 2018 | Sikaria Chanda | 10% Owner | Sell (S) 9 lots, same day | 100K | $29K |
| Nov 16, 2018 | Sikaria Lokesh | 10% Owner | Sell (S) 9 lots, same day | 100K | $29K |
| Nov 16, 2018 | Lokesh Sikaria Trust Dated 12/14/2012 | 10% Owner | Sell (S) 9 lots, same day | 100K | $29K |
| Nov 16, 2018 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 | 10% Owner | Sell (S) 9 lots, same day | 100K | $29K |
| Jul 17, 2018 | Devanur Giri | 10% Owner | Sell (S) | 100K | $227K |
| Jun 7, 2018 | Devanur Giri | 10% Owner | Sell (S) | 329K | $662K |
| Nov 17, 2017 | Rai Dhruwa N | Director | Buy (P) | 145K | $599K |
| Nov 17, 2017 | Devanur Giri | President & CEO | Buy (P) | 12K | $50K |
| Nov 17, 2017 | Lone Star Value Investors LP | 10% Owner | Buy (P) | 100K | $412K |
| Oct 30, 2017 | Lone Star Value Investors GP LLC | 10% Owner | Buy (P) | 1K | $8K |
| Oct 27, 2017 | Lone Star Value Investors GP LLC | 10% Owner | Buy (P) | 3K | $16K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 3 | 2 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for ENVB
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ENVB/capital-change-brief"
Use Arkolith's capital_change_brief for ENVB. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ENVB. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.